European Patients’ Academy on Therapeutic Innovation

European Patients’ Academy on Therapeutic Innovation

Training patients representatative in medicines research & development.

Funding: The project is receiving support from the Innovative Medicines Initiative Joint Undertaking under grant agreement n° 115334,  resources of which are composed of financial contribution from the EU's  7th Framework Programme (FP7/2007-2013) and EFPIA companies.Total amount 70 mDKK fra henholdsvis IMI og den europæiske  forsknings-baserede industri (EFPIA virksomheder herunder Novo Nordisk  A/S i Danmark) Timeline: 2012-2017Description: Medicines  research and development (R&D) is an increasingly complex process  that remains a mystery for the majority of patients and the general  public. Lifting the lid on the medical R&D process is the IMI-funded  EUPATI project. EUPATI is a patient-led initiative that aims to develop  the first European Patients’ Academy on Therapeutic Innovation, with  training courses, educational material and an online public library that  will empower patients to engage more effectively in the development and  approval of new treatments and become true partners in pharmaceutical  R&D.Biopeople's role:
 Biopeople is actively involved in the project and in the development of  the educational material. Biopeople has established a  patient-led national EUPATI platform in Denmark and works to increase  the awareness of the project and its impacting importance.
Project Partners:

  • European Patients’ Forum (EPF) (projektleder)
  • European AIDS Treatment Group (EATG)
  • European Genetic Alliances Network (EGAN)
  • European Organisation for Rare Diseases (EURORDIS)
  • Amgen Belgium SA/NV
  • AstraZeneca AB
  • Bayer Pharma AG
  • Boehringer Ingelheim International GmbH
  • Chiesi Farmaceutici SpA
  • Eli Lilly and Company Ltd
  • Employers' Union of Innovative Pharmaceutical Companies INFARMA
  • F. Hoffmann-La Roche Ltd
  • Farmaindustria, Spain
  • GlaxoSmithKline R&D Ltd
  • Janssen Pharmaceutica NV
  • Laboratorios del Dr Esteve, SA
  • Merck KGaA
  • Novartis Pharma AG
  • Novo Nordisk A/S
  • Sanofi Aventis R&D
  • UCB Pharma SA
  • Verband forschender Artzneimittelhersteller eV
  • DIA Europe GmbH
  • European Forum for Good Clinical Practice
  • European Organisation for Research and Treatment of Cancer
  • Hibernia College
  • International Society for Pharmacoeconomics and Outcomes Research Inc., USA
  • Irish Platform for Patients' Organisations, Science and Industry
  • Nowgen / University of Manchester

Download fact sheetBiopeople contact: Per Spindler and Niels Westergaard

Biopeople is co-funded by the Ministry of Higher Education and Science, Denmark.

Project: European Patients’ Academy on Therapeutic Innovation
Close
What are you looking for?
By using this website, you agree to the use of Cookies to give you the best user experience.Ok